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The I  region of the H-2 complex was originally defined by its regulatory role in the 
immune response to synthetic polypeptides (1). Later, this region was demonstrated to 
control  several other  immunological traits:  strong mixed  lymphocyte reaction  (2,  3), 
graft-vs.-host reaction  (4), serologically detectable  alloantigens  with  restricted  tissue 
distribution  (5, 6), and strong allograff reaction (7). The involvement of the I  region in 
allograft reaction was first demonstrated in vivo by skin grafting of/-region congenic 
lines (7). More recently, we have demonstrated that the I  region contains at least two 
histocompatibility (H) loci: a strong (H-2A) locus in the IA subregion, and a weak (/t- 
2C) locus in the IC subregion (8). We have also demonstrated that in vivo primed and in 
vitro restimulated effector cells lyse labeled target cells in the cell-mediated lympholysis 
(CML) assay in strain combinations differing at the H-2A or H-2C loci (8, 9). Investiga- 
tors in other laboratories have shown that antigens controlled by the I  region can also 
serve as targets in a  CML assay with effector cells produced in vitro (10, 11). In their 
capacity to reject skin grafts rapidly and to serve as targets in the CML assay, the H-2A 
antigens resemble those coded for by the Ho2K and H-2D loci of the H-2 complex and 
differ from all minor H antigens controlled by non-H-2 loci. However, there still remains 
an important difference between the H-2K and H-2D antigens, on the one hand, and H- 
2A antigens on the other hand. Several investigators have demonstrated that specific in 
vitro lysis by effector T cells of virus-infected cells (12, 13), cells chemically modified by 
certain  haptens  (14, 15), or  allogeneic  cells  differing at  minor H  loci  (16, 17)  occurs 
efficiently only when donors of both the T cells and the target cells share an allele at the 
H-2K  or H-2D  loci;  sharing  or nonsharing  of alleles  at  the H-2I  loci  appears to  be 
irrelevant for the occurrence of cell lysis in this system. 
Because of this reported difference between H-2K/D and H-2A antigens,  the 
question  must  be  asked:  do  the  H-2A  antigens  themselves  require  H-2K/D 
identity in order to function as targets in the CML assay? Experiments reported 
in this communication were designed to establish an answer to this question. 
Materials and Methods 
Mice.  All mouse strains used were bred at the University of Texas Health Science Center at 
Dallas. Mice of both sexes and approximately 12-20-wk old were used. 
Skin Grafting.  Skin from the tail was placed on the dorsum of recipient mice according to the 
method described elsewhere  (18), 
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CML Assay.  The assay used was described in detail elsewhere  (8).  The effector cells were 
obtained from spleens of mice presensitized by skin grafting. These spleen cells were restimulated 
in vitro by co-culturing them for 5 days with X-irradiated stimulating cells obtained from the same 
strain that donated the skin grafts. Target cells were blasts stimulated in vitro by concanavalin A 
(Con A).  Each strain combination was tested in three effector:target cell ratios (approximately 
50:1,  25:1,  and  12:1).  The percent release  of 51Cr from the labeled target cells was  calculated 
according to the formula: 
(cpm supernate -  background) ×  2  ×  100. 
(cpm supernate +  pellet) -  2 × background 
Results and  Discussion 
Two  sets  of experiments  were  performed  to  test  whether  H-2A  antigens 
require  H-2K/D identity  to  function  as  CML targets.  In  both  experiments, 
congenic lines were used that differ in the central portion of the H-2 complex 
(including the I  region) but presumably are identical in the remainder of the 
genome.  The two pairs of congenic lines were A.TH-A.TL  and B10.T(6R)- 
B10.AQR. In the former combination, A.TL skin grafts were transplanted  on 
A.TH mice, and at the time when the grafts were being rejected (between 10 
and  14  days after transplantation),  the  recipients  were sacrificed and  their 
spleens were used as the  source of effector cells in the  CML assay.  Upon in 
vitro restimulation  with irradiated A.TL lymphocytes, the effector cells were 
tested,  on the  5th  day of culture,  against  5~Cr-labeled  Con A-blasts derived 
from A.TL  lymphocytes.  Specific lysis,  comparable  in  its  extent to that  ob- 
served  with  strain  combinations  differing  at  the  H-2K  or  H-2D  loci,  was 
observed (Table I). Genetic tests reported by us previously demonstrated that 
this  lysis  is  mediated  by  /-region-controlled  antigens  (8).  To  determine 
whether or not H-2K- or H-2D-  region compatibility was required for this lysis 
to  occur,  the  A.TH  effector cells  sensitized  to  A.TL  stimulating  cells  were 
tested against ~Cr-labeled C3H/HeJ targets. In the A.TH anti-A.TL combina- 
tion,  sensitization  occurs against  I k antigens,  which are  also carried  by the 
C3H/HeJ strain.  However, in the A.TL strain, I ~ occurs in combination with 
H-2K"  and H-2D d (the latter two alleles are also present in the A.TH strain), 
whereas  in  C3H/HeJ,  it  occurs  in  combination  with  H-2K k  and  H-2D k.  If, 
therefore,  sharing  of K  and D  alleles  were not required for/-region  CML to 
occur, the C3H/HeJ cells should also be lysed by the A.TH anti-A.TL effector 
cells.  Table I  shows that  they indeed  are.  The  effector cells are  apparently 
sensitized to antigens controlled by the IA  subregion (in which the H-2A  locus 
resides), since B10.A(4R) cells, which share only the IA  subregion with A.TL, 
were also lysed. As expected, the A.TH anti-A.TL effector cells also lysed A/J 
cells which share with A.TL not only the IA ~" but also the H-2D d allele.  The 
effector cells did not lyse B10.P target cells which differ from A.TL (H-2 ~ ) in 
the entire H-2 haplotype (the B10.P strain is H-2P). 
In the second combination, B10.T(6R) mice were sensitized by grafting with 
B10.AQR skin, and their spleen cells were rechallenged in the CML assay with 
irradiated  B10.AQR lymphocytes. The B10.T(6R) anti-B10.AQR effector cells 
lysed not only B10.AQR but also B10.BR and B10.BYR cells (Table II), again 
indicating  that K  or D  region compatibility was not required for CML lysis 
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TABLE I 
Cell-Mediated Lymphoeytotoxicity  of A .TH Effector Cells Obtained from Mice 
Presensitized  to A.TL by Skin Grafting.  Effector:Target  Cell Ratio 50:1 
H.2 region composition of tar-  Mean net 
Responder  Stimulator  Target  get*  Mean release of  release of 
5'Cr ±  SE 
'~'Cr 
K  A  C  S  G  D 
%  % 
A.TL  A.TH  A.TL  s  k  k  k  k  d  30.3 ±  2.4  - 
A.TH  A.TL  A.TL  s  I  k  k  k  k  I  d  52.5 ±  3.8  22.3 
C3H/HeJ  A.TL  C3H/HeJ  h  k  k  h  k  k  32.1 ±  1.8  - 
A.TH  A.TL  C3H/HeJ  k  [  k  k  k  k  I  k  51.8 -+ 3.5  19.7 
B10.A(4R)  A.TL  B10.A(4R)  k  k  b  b  b  b  30.9 ±  1.9  - 
A.TH  A.TL  B10.A(4R)  k  ~  b  b  b  b  49.8 ±  2.5  18.9 
A]J  A.TL  A/J  h  k  d  d  d  d  33.4 ± 2.1  - 
A.TH  A.TL  A]J  h  ~'~  d  d  d  d  54.1 ± 3.7  17.8 
B10.P  A.TL  B10.P  p  p  p  p  p  p  38.4 ± 4.5  - 
A.TH  A.TL  B10.P  p  p  p  p  p  p  40.1 ±  2.9  1.7 
* Regions to which effector cells can react are boxed. 
TABLE  II 
Cell-Mediated Lymphocytotoxicity of BI O.T(6R) Effector Cells Obtained from Mice 
Presensitized  to BIO.AQR by Skin Grafting.  Effector:Target  Cell Ratio 50:1 
H-2 region composition of tar-  Mean net 
get*  Mean release of 
Reeponder  Stimulator  Target  stCr ±  SE  release of 
~tCr 
K  A  C  S  G  D 
%  % 
B10.AQR  B10.T(6R)  B10.AQR  q  k  d  d  d  d  31.5 ±  3.2  - 
B10.T(6R)  B10.AQR  B10.AQR  q  I  k  d  d  d  d  43.9 ± 3.8  12.4 
B10.BR  B10.AQR  B10.BR  k  k  k  k  k  k  36.7  ±  3.5  - 
B10.T(6R)  B10.AQR  B10.BR  k  [-~  k  k  k  k  46.4 ± 3.4  9.7 
B10.A  B10.AQR  B10.A  k  k  d  d  d  d  33.2 ± 2.7  - 
B10.T(6R)  B10.AQR  B10.A  k  I  k  d  d  d  d  44.5 ± 3.5  11.3 
B10.BYR  B10.AQR  B10.BYR  q  k  d  d  d  b  42.1 ±  3.9  - 
B10.T(6R)  B10.AQR  B10.BYR  q  I  k  d  d  d  b  51.4 ±  4.1  9.3 
B10.M  B10.AQR  B10.M  f  f  f  f  f  f  33.6 ±  2.5  - 
B10.T(6R)  B10.AQR  B10.M  f  f  f  f  f  f  35.2 ±  3.1  1.6 
* Regions to which effector cells can react are boxed. 
cells, but did not lyse B10.M cells. Although the B10.T(6R) anti-B10.AQR cells 
were relatively inefficient effectors in most tests, the results shown in Table II 
were  reproducible  in  repeated  experiments.  Table  I  and  II  show  data  from 
individual experiments;  similar results were obtained in four repeats of each 
experiment. 
The data shown in Tables I and II demonstrate that K/D-region compatibil- 
ity is not needed for/-region CML to occur. In this respect, the H-2A antigens 
behave differently from the minor H antigens, a conclusion which is consistent 
with the rapid rejection of skin grafts across the H-2A barrier  (8).  Neverthe- 
less, one functional difference between H-2K/D and H-2A loci still remains: so 
far, nobody has been able to demonstrate that H-2A antigens, like the H-2K or 
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to mediate CML. However, it is worthwhile to recall that originally/-region 
antigens had been claimed not to be capable of mediating CML at all (19) and 
only a closer look and improved techniques demonstrated incorrectness of this 
claim. Perhaps, the CML-helper capacity of I-region antigens also deserves a 
reinvestigation. 
Summary 
In the cell-mediated lymphocytotoxicity  assay, A.TH effector cells sensitized 
to A.TL lymphocytes lyse not only A.TL but also C3H/HeJ and B10.A(4R) 
targets.  Similarly,  B10.T(6R)  anti-B10.AQR  effector cells  lyse B10.BR  and 
B10.BYR target cells in addition to B10.AQR cells.  These findings indicate 
that for CML to occur across the IA  region barrier,  compatibility at K  or D 
regions is not required. 
We thank Wayne Bundy and Ronald Phillips  for excellent technical assistance and Ms. JoAnne 
Turtle for secretarial  help. 
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